Gynecologic Cancers

Latest News

light blue background with a white outline indicating a clipboard that says FDA
FDA Grants Breakthrough Status to Endometrial Cancer Assay

February 9th 2025

The FDA has granted breakthrough device designation to the ACR-368 OncoSignature assay for use in endometrial cancer.

yellow background with a white outline indicating ovaries and other gynecological structures
Azenosertib Demonstrates Activity and Tolerability in Ovarian Cancer

February 2nd 2025

Close-up blue visual of an ovary with a tumor highlighted in orange
Olaparib Increases OS in Patients with Germline/Somatic BRCA+ Relapsed Ovarian Cancer

January 31st 2025

gynecologic cancer
Lunresertib/Camonsertib Combo Yields Promising Response in Gynecologic Cancers

December 26th 2024

gynecologic system with cancerous tumor
Sacituzumab Tirumotecan Shows Promise in Pretreated Gynecologic Cancer

November 18th 2024

Latest CME Events & Activities

Medical Crossfire®: Real World Strategies to Improve Therapeutic Durability and Outcomes in CLL

February 20, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

View More

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

View More

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

View More

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

View More

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

View More

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

View More

Epithelioid Sarcoma: Applying Clinical Updates to Real Patient Cases

View More

Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma

View More

Mastering Epithelioid Sarcoma: Enhancing Diagnostic Precision and Tailoring Treatment Strategies

View More

Clinical Showcase™: Selecting the Best Next Steps for a Patient with Epithelioid Sarcoma

View More

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!